Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Cotrimoxazole reduces systemic inflammation in HIV infection by altering the gut microbiome and immune activation.

Bourke CD, Gough EK, Pimundu G, Shonhai A, Berejena C, Terry L, Baumard L, Choudhry N, Karmali Y, Bwakura-Dangarembizi M, Musiime V, Lutaakome J, Kekitiinwa A, Mutasa K, Szubert AJ, Spyer MJ, Deayton JR, Glass M, Geum HM, Pardieu C, Gibb DM, Klein N, Edens TJ, Walker AS, Manges AR, Prendergast AJ.

Sci Transl Med. 2019 Apr 3;11(486). pii: eaav0537. doi: 10.1126/scitranslmed.aav0537.

PMID:
30944164
2.

Discontinuing cotrimoxazole preventive therapy in HIV-infected adults who are stable on antiretroviral treatment in Uganda (COSTOP): A randomised placebo controlled trial.

Anywaine Z, Levin J, Kasirye R, Lutaakome JK, Abaasa A, Nunn A, Grosskurth H, Munderi P; COSTOP research team.

PLoS One. 2018 Dec 31;13(12):e0206907. doi: 10.1371/journal.pone.0206907. eCollection 2018.

3.

Cardiometabolic risk among HIV-POSITIVE Ugandan adults: prevalence, predictors and effect of long-term antiretroviral therapy.

Kazooba P, Kasamba I, Mayanja BN, Lutaakome J, Namakoola I, Salome T, Kaleebu P, Munderi P.

Pan Afr Med J. 2017 May 15;27:40. doi: 10.11604/pamj.2017.27.40.9840. eCollection 2017.

4.

From antiretroviral therapy access to provision of third line regimens: evidence of HIV Drug resistance mutations to first and second line regimens among Ugandan adults.

Namakoola I, Kasamba I, Mayanja BN, Kazooba P, Lutaakome J, Lyagoba F, Kapaata AA, Kaleebu P, Munderi P; CoLTART study team.

BMC Res Notes. 2016 Dec 23;9(1):515. doi: 10.1186/s13104-016-2309-7.

5.

Reduced bacterial skin infections in HIV-infected African children randomized to long-term cotrimoxazole prophylaxis.

Prendergast AJ, Bwakura-Dangarembizi M, Mugyenyi P, Lutaakome J, Kekitiinwa A, Thomason MJ, Gibb DM, Walker AS; ARROW Trial Team.

AIDS. 2016 Nov 28;30(18):2823-2829.

6.

A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa.

Bwakura-Dangarembizi M, Kendall L, Bakeera-Kitaka S, Nahirya-Ntege P, Keishanyu R, Nathoo K, Spyer MJ, Kekitiinwa A, Lutaakome J, Mhute T, Kasirye P, Munderi P, Musiime V, Gibb DM, Walker AS, Prendergast AJ.

N Engl J Med. 2014 Jan 2;370(1):41-53. doi: 10.1056/NEJMoa1214901. Erratum in: N Engl J Med. 2014 Jan 30;370(5):488. Dosage error in article text.

7.

Hospitalization for severe malnutrition among HIV-infected children starting antiretroviral therapy.

Prendergast A, Bwakura-Dangarembizi MF, Cook AD, Bakeera-Kitaka S, Natukunda E, Nahirya Ntege P, Nathoo KJ, Karungi C, Lutaakome J, Kekitiinwa A, Gibb DM.

AIDS. 2011 Apr 24;25(7):951-6. doi: 10.1097/QAD.0b013e328345e56b.

PMID:
21487251

Supplemental Content

Loading ...
Support Center